These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2693012)

  • 21. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
    de Meijer PH; Lutterman JA
    Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes.
    Wendt SL; Ranjan A; Møller JK; Schmidt S; Knudsen CB; Holst JJ; Madsbad S; Madsen H; Nørgaard K; Jørgensen JB
    J Diabetes Sci Technol; 2017 Nov; 11(6):1101-1111. PubMed ID: 28654314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures.
    Galloway JA; Spradlin CT; Nelson RL; Wentworth SM; Davidson JA; Swarner JL
    Diabetes Care; 1981; 4(3):366-76. PubMed ID: 7047113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Action profile of human ultralente insulin compared with human NPH-insulin].
    Starke AA; Heinemann L; Hohmann A; Berger M
    Dtsch Med Wochenschr; 1989 Apr; 114(16):618-22. PubMed ID: 2651061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of insulin-dependent diabetes using an injection pen: control, problems and patient preferences.
    Fisken RA; Goulbourn J
    Diabetes Res; 1989 Aug; 11(4):195-7. PubMed ID: 2696619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.
    Thuillier P; Sonnet E; Alavi Z; Roudaut N; Nowak E; Dion A; Kerlan V
    Diabetes Metab Res Rev; 2018 Sep; 34(6):e3019. PubMed ID: 29749032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A subcutaneous insulin pharmacokinetic model for computer simulation in a diabetes decision support role: model structure and parameter identification.
    Wong J; Chase JG; Hann CE; Shaw GM; Lotz TF; Lin J; Le Compte AJ
    J Diabetes Sci Technol; 2008 Jul; 2(4):658-71. PubMed ID: 19885242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes.
    Luzio SD; Beck P; Owens DR
    Horm Metab Res; 2003 Jul; 35(7):434-8. PubMed ID: 12931275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simulation study to determine optimal insulin priming during glucose clamp studies.
    Hovorka R; Powrie JK; Jones RH
    Comput Methods Programs Biomed; 1994 Jan; 41(3-4):231-41. PubMed ID: 8187468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing effect of mixing insulins by glucose-clamp technique in subjects with diabetes mellitus.
    Colagiuri S; Villalobos S
    Diabetes Care; 1986; 9(6):579-86. PubMed ID: 3542452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Miscibility of human and bovine ultralente insulin with soluble insulin.
    Mühlhauser I; Broermann C; Tsotsalas M; Berger M
    Br Med J (Clin Res Ed); 1984 Dec; 289(6459):1656-7. PubMed ID: 6439364
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravenous insulin infusion to simulate subcutaneous absorption. Bioavailability and metabolic sequelae.
    Watanabe RM; Vølund A; Bergman RN
    Diabetes Care; 1991 Nov; 14(11):1021-30. PubMed ID: 1797482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
    Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes mellitus modeling and short-term prediction based on blood glucose measurements.
    Ståhl F; Johansson R
    Math Biosci; 2009 Feb; 217(2):101-17. PubMed ID: 19022264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy.
    Sonnenberg GE; Kemmer FW; Cüppers HJ; Berger M
    Diabetes Care; 1983; 6 Suppl 1():35-9. PubMed ID: 6343035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nighttime insulin kinetics and glycemic control in type 1 diabetes patients following administration of an intermediate-acting lispro preparation.
    Janssen MM; Casteleijn S; Devillé W; Popp-Snijders C; Roach P; Heine RJ
    Diabetes Care; 1997 Dec; 20(12):1870-3. PubMed ID: 9405909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorption rates of subcutaneously injected insulin in the dog as calculated from the plasma insulin levels by means of a simple mathematical model.
    Fischer U; Freyse EJ; Jutzi E; Besch W; Raschke M; Höfer S; Albrecht G
    Diabetologia; 1983 Mar; 24(3):196-201. PubMed ID: 6341148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of conventional and intensified insulin therapy on free-insulin profiles and glycemic control in NIDDM.
    Lindström TH; Arnqvist HJ; von Schenck HH
    Diabetes Care; 1992 Jan; 15(1):27-34. PubMed ID: 1737539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absorption, effectiveness and side effects of highly purified porcine NPH-insulin preparations (Leo).
    Kølendorf K; Aaby P; Westergaard S; Deckert T
    Eur J Clin Pharmacol; 1978 Nov; 14(2):117-24. PubMed ID: 363432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.